Infinity Pharma
INFIQ0.00010.00% ( 0.0000 )
Infinity Pharma (INFIQ)
Infinity Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel medicines for people with cancer. The company’s product...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- 0.0001
- Volume
- 1.51K
- Turnover
- 0
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- 0.0026
- Volume Ratio
- 0.45
- Turnover Ratio
- 0.00%
- 52wk Low
- --
- Float Mkt Cap
- 9.08K
- Market CapUSD
- 9.08K
- P/ETTM
- Loss
- P/EDynamic
- Loss
- P/EStatic
- --
- EPSTTM
- -0.460
- EPSDynamic
- -0.469
- EPSStatic
- --
- BVPS
- -0.41
- P/B
- --
- Circulating Supply
- 90.76M
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- 90.76M
- Min lot size
- 1
- Currency
- USD
Infinity Pharma Analyst Rating
View moreForecast & Rating
May 31, 2023Price forecast
$0.30299900.00%
Forecast & RatingHold
1analysts
- Strong buy0.00%
- Buy0.00%
- Hold100.00%
- Sell0.00%
- Strong sell0.00%
News
- Unusual Whales ·
Infinity and HP Deliver 2X Performance Gains on NVIDIA's GB300 Grace Blackwell Ultra Desktop Superchip
- benzinga_article ·
Merck Locks Infinimmune Alliance To Chase Next-Gen Antibody Drugs
- Pharmexec ·
<![CDATA[Pharmaceutical Executive Daily: Novo Nordisk's Wegovy Subscription Program]]>
- Pharmexec ·
<![CDATA[Merck Enters $838 Million Research & Development Collaboration with Infinimmune ]]>
